( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...